Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10851
ImmuCell
ICCC
$91.3M
| $149K | ﹤0.01% |
+29,021
| New | +$116K |
|
10852
CALL
CoinShares Bitcoin and Ether ETF
BTF
$13.6M
| $149K | ﹤0.01% |
2,040
-460
| -18% | -$45K |
|
10853
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$28M
| $149K | ﹤0.01% |
+2,997
| New | +$401K |
|
10854
Nuveen Floating Rate Income Fund
JFR
$1.23B
| $149K | ﹤0.01% |
+16,726
| New | +$150K |
|
10855
PUT
Mine Safety
MSA
$7.3B
| $149K | ﹤0.01% |
900
-6,700
| -88% | -$1.15M |
|
10856
CALL
Bioventus
BVS
$1.2B
| $149K | ﹤0.01% |
14,200
-1,100
| -7% | -$13K |
|
|
SPHL
10857
Springview Holdings
SPHL
$6.15M
| $149K | ﹤0.01% |
+2,870
| New | +$110K |
|
10858
CALL
Acacia Research
ACTG
$448M
| $149K | ﹤0.01% |
34,300
+33,300
| +3,330% | +$151K |
|
10859
CALL
Entrada Therapeutics
TRDA
$290M
| $149K | ﹤0.01% |
8,600
+3,800
| +79% | +$68.8K |
|
10860
VanEck Long Muni ETF
MLN
$681M
| $149K | ﹤0.01% |
+8,311
| New | +$150K |
|
10861
CALL
Kornit Digital
KRNT
$775M
| $149K | ﹤0.01% |
4,800
-1,800
| -27% | -$51.6K |
|
|
BELFB
10862
CALL
Bel Fuse Inc Class B
BELFB
$4.19B
| $148K | ﹤0.01% |
1,800
-7,100
| -80% | -$574K |
|
10863
PUT
Editas Medicine
EDIT
$433M
| $148K | ﹤0.01% |
116,800
+49,500
| +74% | +$126K |
|
|
OLO
10864
PUT
DELISTED
Olo Inc
OLO
| $148K | ﹤0.01% |
19,300
+7,200
| +60% | +$45K |
|
|
CSGS
10865
PUT
DELISTED
CSG Systems International
CSGS
| $148K | ﹤0.01% |
2,900
-6,100
| -68% | -$314K |
|
10866
Teucrium Soybean Fund
SOYB
$60.9M
| $148K | ﹤0.01% |
6,891
+4,799
| +229% | +$103K |
|
10867
US Commodity Index
USCI
$375M
| $148K | ﹤0.01% |
2,243
-12,763
| -85% | -$818K |
|
10868
GrowGeneration
GRWG
$104M
| $148K | ﹤0.01% |
87,568
+7,490
| +9% | +$14.3K |
|
10869
Summit State Bank
SSBI
$87.4M
| $148K | ﹤0.01% |
19,370
+5,888
| +44% | +$43K |
|
|
CVGW
10870
PUT
DELISTED
Calavo Growers
CVGW
| $148K | ﹤0.01% |
+5,800
| New | +$158K |
|
10871
Global X Genomics & Biotechnology ETF
GNOM
$85.4M
| $148K | ﹤0.01% |
+3,804
| New | +$160K |
|
10872
Stereotaxis
STXS
$138M
| $148K | ﹤0.01% |
64,752
+10,435
| +19% | +$21.8K |
|
10873
PUT
VanEck Mortgage REIT Income ETF
MORT
$375M
| $148K | ﹤0.01% |
13,900
+8,100
| +140% | +$91.2K |
|
10874
PUT
Rekor Systems
REKR
$98.2M
| $147K | ﹤0.01% |
94,500
+70,500
| +294% | +$73.2K |
|
10875
PUT
Invesco DB Oil Fund
DBO
$391M
| $147K | ﹤0.01% |
10,300
+1,000
| +11% | +$14.5K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.